World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
49
Citations
9302
World Ranking
4333
National Ranking
375

Rosemary J. Boyton publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Rosemary J. Boyton sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 150 publications — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Rosemary J. Boyton D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Rosemary J. Boyton sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 49 D-Index — 13th percentile

13% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Best Publications

  • Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure

    Unknown

  • Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inflammatory responses: a randomised cross-over trial

    Edward S Chambers;Claire S Byrne;Douglas J Morrison;Kevin G Murphy

  • Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2.

    Leo Swadling;Mariana O. Diniz;Nathalie M. Schmidt;Oliver E. Amin

  • Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals.

    Charlotte Manisty;Ashley D Otter;Thomas A Treibel;Áine McKnight

  • The immunology of long COVID

    Unknown

  • Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose.

    Catherine J. Reynolds;Corinna Pade;Joseph M. Gibbons;David K. Butler

  • What policy makers need to know about COVID-19 protective immunity.

    Daniel M Altmann;Daniel C Douek;Rosemary J Boyton

  • Innate immunity in multiple sclerosis white matter lesions: expression of natural cytotoxicity triggering receptor 1 (NCR1).

    Pascal F Durrenberger;Anna Ettorre;Fatemah Kamel;Louise V Webb

  • SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection.

    Daniel M. Altmann;Rosemary J. Boyton

  • Peptide immunotherapy in allergic asthma generates IL-10–dependent immunological tolerance associated with linked epitope suppression

    John D M Campbell;Karen F. Buckland;Sarah J. McMillan;Jennifer Kearley

  • Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2

    Ian McDonald;Sam M. Murray;Catherine J. Reynolds;Daniel M. Altmann

  • COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study

    Unknown

  • Natural killer cells, killer immunoglobulin‐like receptors and human leucocyte antigen class I in disease

    R. J. Boyton;D. M. Altmann

  • Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection.

    Catherine J. Reynolds;Leo Swadling;Joseph M. Gibbons;Corinna Pade

  • COVID-19 vaccination: The road ahead

    Unknown

  • Immunity to SARS-CoV-2 variants of concern.

    Daniel M. Altmann;Rosemary J. Boyton;Rupert Beale;Rupert Beale

  • Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: Implications for immunotherapy.

    David J. Pinato;Sam M Murray;Alejandro Forner;Takahiro Kaneko

  • Pulmonary defences to acute respiratory infection.

    Rosemary J Boyton;Peter J Openshaw

  • Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants.

    Catherine J Reynolds;Joseph M Gibbons;Corinna Pade;Kai-Min Lin

  • Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers.

    Letícia Adrielle dos Santos;Pedro Germano de Góis Filho;Ana Maria Fantini Silva;João Victor Gomes Santos

Frequent Co-Authors

Daniel M. Altmann
Daniel M. Altmann Imperial College London
James C. Moon
James C. Moon University College London
Áine McKnight
Áine McKnight Queen Mary University of London
Mahdad Noursadeghi
Mahdad Noursadeghi University College London
David Butler
David Butler University of Exeter
Mala K. Maini
Mala K. Maini University College London
Benjamin M. Chain
Benjamin M. Chain University College London
Ana M. Valdes
Ana M. Valdes University of Nottingham
Susanna Dunachie
Susanna Dunachie University of Oxford
Nigel J. Temperton
Nigel J. Temperton University of Kent

External Links

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Rosemary J. Boyton

Recently Published Articles